Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

Objective To assess the outcomes of several rodent animal models for studying tooth
extraction-related medication-related osteonecrosis of the jaw (MRONJ). Design After a …

Purpose Bisphosphonates related osteonecrosis of jaw (BRONJ) is a severe complication of
systemic BPs administration, the mechanism of which is still unclarified. Recently, platelet …

This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-
related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as …

Purpose The aim was to assess the effect of a relevant regimen of zoledronic acid (ZA)
treatment for the study of bisphosphonate-related osteonecrosis of the jaw on alveolar bone …

Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a well known side-effect
of anti-resorptive drugs. Changes in bone density might potentially constitute the …

Introduction Medication-related osteonecrosis of the jaws (MRONJ) is a known adverse
event related to the use of antiresorptive (AR) drugs. More recently, an association between …

Objectives Nitrogen-containing bisphosphonates induce osteonecrosis mostly in the jaw
and less frequently in other bones. Because of the crucial role of periosteal perfusion in …

Medication-related osteonecrosis of the jaws (MR-ONJ) is one of the most relevant side
effects of bisphosphonate therapy; it is clinically defined as a non-healing wound in …

Introduction The treatment of bisphosphonate-related osteonecrosis of the jaw has become
routine in maxillofacial hospitals. However, the etiopathology has not yet been fully …